Supplementary Data from Preclinical Development of MGC028, an ADAM9-Targeted, Glycan-Linked, Exatecan-Based Antibody–Drug Conjugate for the Treatment of Solid Cancers

2026 Open access

Read full text
Authors: Juniper A. Scribner, Jennifer G. Brown, Thomas Son, Linda X. Jin, Carroll McKenzie, Viktoriya Nam, Curtis Bush, Dienis Quinonez, Delta Ford, James K. Tamura, Sergey N. Gorlatov, Angela Summers
+8 more Monirath Hav, Hua Li, Neel Kamal Sharma, Xiaoyan Zhang, Gundo Diedrich, Shelley Ruth Butler, Ezio Bonvini, Deryk T. Loo
DOI: 10.1158/1535-7163.31923511
Cited by: 1

Fields of Study & Subjects

HER2/EGFR in Cancer Research Glycosylation and Glycoproteins Research Monoclonal and Polyclonal Antibodies Research

Publication details

Publisher
American Association for Cancer Research (AACR)
Publication date
2 April 2026